Lipid Lowering Drugs: Present Status and Future Developments

PURPOSE OF REVIEW: Based on the recent data of the DA VINCI study, it is clear that, besides utilization of statins, there is a need to increase non-statin lipid lowering approaches to reduce the cardiovascular burden in patients at highest risk. RECENT FINDINGS: For hypercholesterolemia, the small...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruscica, Massimiliano, Ferri, Nicola, Santos, Raul D., Sirtori, Cesare R., Corsini, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Statin Drugs (R. Ceska, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946696/
https://www.ncbi.nlm.nih.gov/pubmed/33694108
http://dx.doi.org/10.1007/s11883-021-00918-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946696/
https://www.ncbi.nlm.nih.gov/pubmed/33694108
http://dx.doi.org/10.1007/s11883-021-00918-3

Ejemplares similares